PacMab.com
About PacMab.com
PacMab was established in 2001 to develop and commercialise Mab technology for the treatment of blood cancers and other blood disorders. Its Mab technology is based on over ten years of research conducted at the University of Technology, Sydney. The company was co-founded by UTS scientists who now form the core of the company's drug development team. Chief Executive Officer, Alan Liddle and Malcom Castle are also co-founders of the company, and provide PacMab's business leadership.
